Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

allopurinol sodium

The sodium form of allopurinol, which is a structural isomer of hypoxanthine. Allopurinol inhibits xanthine oxidase, an enzyme that converts oxypurines to uric acid. By blocking the production of uric acid, this agent decreases serum and urine concentrations of uric acid, thereby providing protection against uric acid-mediated end organ damage in conditions associated with excessive production of uric acid, i.e. the massive cell lysis associated with the treatment of some malignancies.
Synonym:Alositol
Anoprolin
Anzief
Apurol
Bleminol
Bloxanth
Embarin
Epidropal
Foligan
Geapur
Ketobun-A
Urbol
Uricemil
Urosin
Xanturat
Zyloric
US brand name:Aloprim
Zyloprim
Foreign brand name:Adenock
Allo-Puren
Allozym
Allural
Aloral
Alositol
Anoprolin
Anzief
Apulonga
Apurin
Apurol
Bleminol
Bloxanth
Caplenal
Cellidrin
Cosuric
Dabroson
Embarin
Epidropal
Foligan
Geapur
Gichtex
Hamarin
Hexanurat
Ketanrift
Ketobun-A
Ledopur
Lysuron
Miniplanor
Monarch
Nektrohan
Remid
Riball
Suspendol
Takanarumin
Urbol
Uricemil
Uripurinol
Urosin
Urtias
Xanturat
Zyloric
Code name:BW-56158
Chemical structure:1,5-dihydro-4H-pyrazolo[3,4-d]pryimidin-4-one monosodium salt
1H-pyrazolo[3,4-d]pyrimidin-4-ol monosodium salt
Search NCI's Drug Dictionary